Golden Helix Blog

Using Gene Preferences in VarSeq and VSClinical

Apr 20, 2021

With the latest release of VarSeq, we have made significant updates to our handling of the interaction of variants and genes. This includes the support for non-coding transcripts, improved splice site predictions, and updates to gene and transcript annotations. We received several questions regarding how decisions are made in the…

Read more →

VarSeq Update: Support for the Interpretation of Non-coding and Splice Site Variants

Apr 15, 2021

While VarSeq has always had excellent support for variant interpretation and analysis, we continue to find new edge cases in the clinical literature that improve our interpretation capabilities. In this blog, we will be covering some of the new improvements in VarSeq to support the interpretation of non-coding and splice…

Read more →

Featured in The Journal of Precision Medicine: Implementing the ACMG Guidelines for CNV in a Commercial Software Solution

Apr 8, 2021

We are excited to share our latest publication with The Journal of Precision Medicine, “Implementing the ACMG Guidelines for CNV in a Commercial Software Solution”. “In 2020, ACMG in collaboration with the ClinGen working group developed a new set of guidelines for the clinical interpretation of CNVs. While theseguidelines provide…

Read more →

Webcast Recap: Exome Analysis with VS-CNV and VSClinical: Updated Strategies and Expanded Capabilities

Apr 8, 2021

Thank you to those who attended the recent webcast, “Exome Analysis with VS-CNV & VSClinical: Updated Strategies & Expanded Capabilities”. For those who could not attend but wish to watch, here is a link to the recording. In this webcast, we covered the capabilities and updates that have been incorporated…

Read more →

GenomeAsia 100K Variant Frequency Annotation

Mar 30, 2021

The GenomeAsia 100K Variant Frequency database is a pilot annotation source now available to our users. This valuable database offers a deep characterization of specific populations in Asia that can be used to drive genetic studies. GenomeAsia is comprised of whole-genome sequencing data of over 1,000 individuals from 219 populations…

Read more →

Customer Publications – March 2021

Mar 25, 2021

Breakthroughs and discoveries in personalized medicine occur every day and here at Golden Helix, we are proud to play a role in so many cutting-edge investigations. It is always my pleasure to provide a brief description of what is only a small sample of our customer success stories over the…

Read more →

New Assessment Catalogs Improve Saving and Tracking Variant Interpretations

Mar 23, 2021

In this blog, we will be covering new assessment catalogs and how they work to improve saving and tracking variant interpretations. VarSeq is a variant analysis tool that effectively analyzes single nucleotide (SNVs) and copy number variants (CNVs) in both cancer and germline workflows.  Because VarSeq enables such diverse variant…

Read more →

Orphanet Annotations in VarSeq

Mar 18, 2021

Orphanet is a public database available in VarSeq that aims to improve the current understanding and treatment options for patients affected by rare diseases. This resource was established in France in 1997 and has gradually grown to cover a consortium of over 40 countries in Europe. The primary goal of…

Read more →

2021 Abstract Competition Winners

Mar 16, 2021

We would like to thank everyone who entered our 2021 Abstract Competition. It is wonderful to read about the different ways Golden Helix software is being applied around the world. It is our pleasure to announce this year’s winners! First Place: Viney Gupta – All India Institute of Medical Sciences…

Read more →

Webcast Recap: VSWarehouse: Tracking Changing Variant Evidence and Classifications

Mar 11, 2021

Thank you to those who attended the recent webcast, “VSWarehouse: Tracking Changing Variant Evidence and Classifications”. For those who could not attend but wish to watch, here is a link to the recording. The webcast covered some general highlights of VSWarehouse value but also presented some specific capabilities covering the…

Read more →

Customizing New VSClinical Report Templates

Mar 9, 2021

Clinical testing labs produce reports as the end product of the NGS variant detection and interpretation workflow. Necessarily, the content, detail, and presentation of the report needs to be specialized to each clinical lab, and potentially each offered test. Our last blog post introduced the new Word-based report templates in…

Read more →

Implementation of ClinGen Dosage Sensitivity in VSClinical

Mar 4, 2021

The collaboration between the Clinical Genome Resource (ClinGen) consortium and the American College of Medical Genetics (ACMG) recently developed published guidelines for the interpretation of CNVs called on next-generation sequencing data. These new guidelines are the first to provide a robust set of rules for the interpretation of small intragenic…

Read more →

New eBook Update: Clinical Variant Analysis – Second Edition

Mar 4, 2021

This morning I released a new version of my eBook “Clinical Variant Analysis – Second Edition.” The clinical interpretation of variants in Next-Gen Sequencing is a quickly evolving field. While the body of knowledge is growing exponentially, experts have to derive sound, clinical decisions leveraging an ever-expanding set of specialty databases,…

Read more →

New Mendel Error Algorithm in VarSeq

Mar 2, 2021

In many cases, VarSeq users typically run single trio projects or perhaps an extended family project. Not only are all the inheritance model algorithms available in the VarSeq software to capture de novo, dominant, or recessively inherited variants but there are a number of quality control fields to help ensure…

Read more →

Lock in Annotation Source Versions to Increase Workflow Consistency

Feb 25, 2021

Next-generation sequencing generates an immense amount of data which is then subject to a multi-step process to establish a validated bioinformatic pipeline. From processing raw sequence data to the detection of genetic mutations, establishing a validated and consistent bioinformatic pipeline makes a huge difference in the quality of patient care…

Read more →

Customer Publications February 2021: The Heart Edition

Feb 23, 2021

Welcome to our Customer Publications for February 2021, dedicated to cardiac research. As we commemorate the 57th American Heart Month, it is important to remember why we are wearing red and using #OurHearts. Heart disease is the leading cause of death worldwide. The National Heart, Lung, and Blood Institute urges…

Read more →

New VSClinical ACMG Word Report Templates

Feb 18, 2021

The recent release of VarSeq 2.2.2 brings our Word report template system, previously featured in VSClinical AMP, to the VSClinical ACMG workflow. This blog post will describe how to use the Word template system using one of our shipped templates as well as how to start customizing your own templates.…

Read more →

New CNV Tools with VarSeq 2.2.2 Update

Feb 16, 2021

Our latest release of the VarSeq software has had a major upgrade with the addition of the new CNV ACMG guidelines! Here are some recent webcasts we’ve given covering the new guideline tool: Family-Based Workflows in VarSeq and VSClinical A User’s Perspective: ACMG Guidelines for CNVs in VSClinical Not only…

Read more →

New Annotation: GnomAD – Gene Constraints

Feb 10, 2021

VarSeq recently received major upgrades in a wide range of areas, one of these areas includes adding annotations such as GnomAD. This includes new fundamental methods of CNV ACMG guideline processing but also a large number of small additions in annotations. One addition is the application of gnomADs – Gene…

Read more →

Applying the Probability Segregation Algorithm for CNV Analysis

Feb 4, 2021

VarSeq 2.2.2 has incorporated a multitude of interesting new features. In this blog, I want to continue discussing these features and how each can be incorporated into your workflow. I will also discuss the application of the Probability Segregation algorithm for copy number variation (CNV) analysis. The Probability Segregation algorithm…

Read more →